دورية أكاديمية

Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study.

التفاصيل البيبلوغرافية
العنوان: Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study.
المؤلفون: Català, Alba, Galván-Casas, Cristina, Carretero-Hernández, Gregorio, Rodríguez-Jiménez, Pedro, Fernández-Nieto, Daniel, Rodríguez-Villa, Ana, Navarro-Fernández, Íñigo, Ruiz-Villaverde, Ricardo, Falkenhain-López, Daniel, Llamas-Velasco, Mar, Carnero-Gonzalez, Lucía, García-Gavin, Juan, Baniandrés, Ofelia, González-Cruz, Carlos, Morillas-Lahuerta, Víctor, Cubiró, Xavier, Figueras, Ignasi, Selda-Enriquez, Gerald, Fustà-Novell, Xavier, Roncero-Riesco, Mónica, Burgos-Blasco, Patrícia, Romaní, Jorge, Solà-Ortigosa, Joaquim, García-Doval, Ignacio
سنة النشر: 2020
المجموعة: Sistema Sanitario Público de Andalucía (SSPA): Repositorio
مصطلحات موضوعية: COVID-19, coronavirus, cutaneous manifestations, skin, Adolescent, Adult, Aged, 80 and over, Antiviral Agents, Cross-Sectional Studies, Female, Host-Pathogen Interactions, Humans, Male, Middle Aged, Risk Factors, SARS-CoV-2, Skin Diseases, Viral, Spain, Young Adult, COVID-19 Drug Treatment
الوصف: A previous study has defined the maculopapular subtype of manifestations of COVID-19. The objective of our study was to describe and classify maculopapular eruptions associated with COVI-19. We carried out a subanalysis of the maculopapular cases found in the previous cross-sectional study. Using a consensus, we defined seven clinical patterns. We described patient demographics, the therapy received by the patient and the characteristics of each pattern. Consensus lead to the description of seven major maculopapular patterns: morbilliform (45.5%), other maculopapular (20.0%), purpuric (14.2%), erythema multiforme-like (9.7%), pytiriasis rosea-like (5.7%), erythema elevatum diutinum-like (2.3%), and perifollicular (2.3%). In most cases, maculopapular eruptions were coincident (61.9%) or subsequent (34.1%) to the onset of other COVID-19 manifestations. The most frequent were cough (76%), dyspnea (72%), fever (88%), and astenia (62%). Hospital admission due to pneumonia was frequent (61%). Drug intake was frequent (78%). Laboratory alterations associated with maculo-papular eruptions were high C-reactive protein, high D-Dimer, lymphopenia, high ferritin, high LDH, and high IL-6. The main limitation of our study was the impossibility to define the cause-effect relationship of each pattern. In conclusion, we provide a description of the cutaneous maculopapular manifestations associated with COVID-19. The cutaneous manifestations of COVID-19 are wide-ranging and can mimic other dermatoses.
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
تدمد: 1529-8019
العلاقة: http://hdl.handle.net/10668/16085Test; PMC7436694; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436694Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436694/pdfTest
DOI: 10.1111/dth.14170
الإتاحة: https://doi.org/10.1111/dth.14170Test
http://hdl.handle.net/10668/16085Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436694Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436694/pdfTest
حقوق: open access
رقم الانضمام: edsbas.51B7FF69
قاعدة البيانات: BASE
الوصف
تدمد:15298019
DOI:10.1111/dth.14170